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Acetylcholine (ACh) release onto nicotinic receptors directly activates subsets of
inhibitory interneurons in hippocampal CA1. However, the specific interneurons activated
and their effect on the hippocampal network is not completely understood. Therefore,
we investigated subsets of hippocampal CA1 interneurons that respond to ACh release
through the activation of nicotinic receptors and the potential downstream effects this
may have on hippocampal CA1 network function. ACh was optogenetically released in
mouse hippocampal slices by expressing the excitatory optogenetic protein oChIEF-
tdTomato in medial septum/diagonal band of Broca cholinergic neurons using Cre
recombinase-dependent adeno-associated viral mediated transfection. The actions of
optogenetically released ACh were assessed on both pyramidal neurons and different
interneuron subtypes via whole cell patch clamp methods. Vasoactive intestinal peptide
(VIP)-expressing interneurons that selectively innervate other interneurons (VIP/IS) were
excited by ACh through the activation of nicotinic receptors containing α4 and β2
subunits (α4β2*). ACh release onto VIP/IS was presynaptically inhibited by M2 muscarinic
autoreceptors. ACh release produced spontaneous inhibitory postsynaptic current
(sIPSC) barrages blocked by dihydro-β-erythroidine in interneurons but not pyramidal
neurons. Optogenetic suppression of VIP interneurons did not inhibit these sIPSC
barrages suggesting other interneuron-selective interneurons were also excited by
α4β2* nicotinic receptor activation. In contrast, interneurons that innervate pyramidal
neuron perisomatic regions were not activated by ACh release onto nicotinic receptors.
Therefore, we propose ACh release in CA1 facilitates disinhibition through activation of
α4β2* nicotinic receptors on interneuron-selective interneurons whereas interneurons
that innervate pyramidal neurons are less affected by nicotinic receptor activation.
Keywords: optogenetics, nicotinic receptor, CA1, hippocampus, interneuron-selective interneuron, disinhibition
Introduction
The formation of new memories in the hippocampus is influenced by nicotinic receptor
function. This is exemplified by observations that the encoding of memories can be enhanced
by the exogenous activation of nicotinic receptors (Davis and Gould, 2006; Levin et al., 2009)
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and memory performance can be impaired by the injection
of α4β2∗ (nicotinic receptors that contain α4 and β2 subunits
but may include other types of subunits) or α7 nicotinic
receptor antagonists directly into the hippocampus (Levin, 2002).
Furthermore, dysfunction of both α4 and β2 nicotinic subunits in
the hippocampus have been correlated with memory impairment
associated with addiction, neurodegenerative disease and aging.
In regard to nicotine addiction, the β2 nicotinic subunit in the
hippocampus has been linked to chronic nicotine withdrawal
(Davis and Gould, 2009) and high affinity nicotinic receptors in
the hippocampus, which are likely composed of α4β2∗ subunits
(Nguyen et al., 2004), are upregulated in smokers (Perry et al.,
1999). In terms of aging and neurodegenerative disease, a
significant loss of α4 nicotinic receptor subunit expression has
been observed in aging mice (Gahring et al., 2005) and an
80% decrease in α4 subunit expression has been reported in
Alzheimer’s patients (Kellar et al., 1987). Furthermore, beta
amyloid protein, a protein that has been associated with the
etiology of Alzheimer’s disease, can inhibit α4β2∗ receptors
at low concentrations (Wu et al., 2004). Therefore, it appears
that α4β2∗ nicotinic receptor function in the hippocampus is
necessary for normal memory formation and their dysfunction
may contribute tomemory impairment associated with aging and
neurodegenerative disease.
In the mammalian central nervous system, 11 nicotinic
receptor subunits have been identified, 9 of which have been
found in the hippocampus (Sudweeks and Yakel, 2000). A
significant portion of the influence that nicotinic receptor
activation has on hippocampal network function is likely due to
the expression of nicotinic receptors on inhibitory interneurons.
In particular, α7 (Alkondon et al., 1997; Jones and Yakel,
1997; Frazier et al., 1998b; McQuiston and Madison, 1999),
α4β2∗ (McQuiston and Madison, 1999; Sudweeks and Yakel,
2000) and α2 nicotinic receptors (McQuiston and Madison,
1999; Sudweeks and Yakel, 2000; Jia et al., 2009) have
been shown to be functionally expressed on various subsets
of hippocampal interneurons. Furthermore, electrically-evoked
release of Acetylcholine (ACh) has been shown to result in α7
nicotinic receptor mediated excitatory postsynaptic responses
in CA1 interneurons (Alkondon et al., 1998; Frazier et al.,
1998a). Based on the identification of α7-mediated nicotinic
synaptic events and the prevalence of functional α7 nicotinic
responses in interneurons, α7 subunits had been thought to
be the primary subunits mediating nicotinic receptor activation
of hippocampal inhibitory interneurons. However, more recent
studies that utilized optogenetics to release ACh from medial
septum/diagonal band of Broca (MS/DBB) axon terminals
in mouse hippocampal CA1 showed that nicotinic EPSPs
in interneurons were almost exclusively mediated by α4β2∗
nicotinic receptors (Bell et al., 2011). These latter studies fit with
behavioral studies that suggested that α4β2∗ nicotinic receptors
may have a significant role in nicotine enhancement of memory
processing (Davis and Gould, 2006).
Given the importance of α4β2∗ nicotinic receptors in
normal and pathophysiological nervous system function, it is
crucial to identify neuronal types endogenously activated by
nicotinic receptors. Although it is known that α4β2∗ nicotinic
receptors on hippocampal CA1 interneurons can be activated
by ACh release from MS/DBB terminals (Bell et al., 2011),
the identity of the specific subsets of interneurons displaying
α4β2∗ nicotinic responses remains unknown. Therefore,
using Cre-driver mice, fluorescent protein reporter mice, and
optogenetics, we have investigated the subsets of hippocampal
CA1 interneurons that respond with nicotinic responses
following the release of ACh.
Methods
Animals
Viptm1(cre)Zjh/J (VIP-Cre, JAX Stock No. 010908), B6;129P2-
Pvalbtm1(cre)Arbr/J (PV-cre, Jax Stock No. 008069), B6;129S6-
Chattm1(cre)Lowl/J (Chat-Cre, JAX Stock No. 006410),
B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze/J (YFP, Jax Stock No.
007903), and B6;129S-Gt(ROSA)26Sortm35.1(CAG-aop3/GFP)Hze/J
(Arch-GFP, Jax Stock No. 012735) mice (Hippenmeyer et al.,
2005; Madisen et al., 2010; Rossi et al., 2011; Taniguchi et al.,
2011) used in these studies were housed in an animal care facility
approved by the American Association for the Accreditation
of Laboratory Animal Care (AAALAC). Animal experimental
procedures followed a protocol approved by the Institutional
Animal Care and Use Committee of Virginia Commonwealth
University (AD20205). This protocol adhered to the ethical
guidelines described in The Care and Use of Laboratory Animals
8th Edition (Garber et al., 2011). All efforts were made to
minimize animal suffering and to reduce the number of animals
used.
Breeding Strategies and Chat
Immunofluorescence
Two different breeding strategies were developed for these
studies. Studies examining nicotinic responses in interneuron
subtypes utilized a triple cross consisting of Chat-Cre× VIP-Cre
× YFP-reporter (CVY). Studies that utilized archaerhodopsin to
silence specific interneuron subtypes in CA1 used a triple cross
consisting of Chat-Cre × VIP-Cre × Arch-GFP (CVA) (see Bell
et al., 2015 for more details).
Generation and Stereotaxic Injection of
rAAV-Flex-rev-oChIEF-tdTomato into the
MS/DBB of Chat-Cre Mice
A recombinant adeno-associated virus (rAAV, serotype 1, 1.05 or
1.8 × 1013 VC/ml titer) expressing FLEXed oChIEF-tdTomato
was generated using a previously described method (Bell et al.,
2011) in order to selectively express oChIEF-tdTomato in
infected cells that also expressed Cre recombinase. Mice were
initially anesthetized via intraperitoneal injection of ketamine
(100 mg/kg IP) and xylazine (2.5 mg/kg IP). Anesthesia was
maintained with O2 supplemented with isoflurane.
For injections into the MS/DBB, an incision was made in
the skin along the midsagittal suture, and a small hole was
drilled in the skull overlying the septum. An aluminosilicate
glass pipette containing rAAV-Flex-rev-oChIEF-tdTomato was
lowered to the level of the MS/DBB, 1.0 mm rostral to
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Bregma and infused at a rate of 100 nl/min using a software
driven injectomate (Neurostar, Sindelfingen, Germany). In total,
7 × 100 nl injections were made between 3.75 and 5.0 mm in
depth. For injections into the left nucleus basalis, coordinates
were AP = −0.5, Lat = −1.6, Depth = 5.0–4.2 mm, and injection
volume was 100 nl/site every 200 µm for a total of 500 nl. 10–15
days post viral injection, 42–70 day old mice were sacrificed for
experimentation.
Preparation of Hippocampal Slices
Brain slices were obtained by methods previously described (Bell
et al., 2011). In brief, horizontal slices containing the mid-
temporal hippocampus were cut at 350–450 µm on a Leica
VT1200 (Leica Microsystems, Buffalo Grove, IL). Sections were
incubated in a holding chamber kept at 36◦C for 30 min and
then allowed to return to room temperature. The holding and
recording chamber solution consisted of normal saline (in mM):
NaCl 125, KCl 3.0, CaCl2 1.2, MgSO4 1.2, NaHPO4 1.2, NaHCO3
25, glucose 25 bubbled with 95% O2/5% CO2. Recordings were
performed at 32–35◦C.
Light-Evoked Release of ACh from MS/DBB
Cholinergic Axon Terminals and Light-Evoked
Silencing of CA1 Interneuron Subtype
Populations
Cholinergic terminals expressing oChIEF-tdTomato were
stimulated by blue light and interneurons expressing Arch-
GFP were hyperpolarized by yellow light. Both light paths
were transmitted through the epi-illumination light path of an
Olympus BX51WI microscope and a 10× water immersion
objective (0.3 NA). Blue light flashes (1 ms in duration) and
yellow light pulses (4 s in duration) were generated from
light-emitting diodes (LEDs) (UHP-microscope-LED-460 or
UHP-T-LED-White filtered by an HQ 575/50x excitation filter,
respectively, Prizmatix Modiin-Ilite, Givat Shmuel, Israel). Blue
or yellow light exiting the LEDs were reflected or passed through
a dichroic mirror (515dcxru, Chroma Technology, Bellows
Falls, VT, USA) and were focused into the epi-illumination
light path of the Olympus BX51WI microscope and back
aperture of the 10x water immersion objective (0.3 NA) using
an optiblock beam combiner (Prizmatix) and a dichroic mirror
(700dcxxr, Chroma Technology, Bellows Falls, VT, USA) in the
filter turret.
Electrophysiological Measurements
Whole cell patch clamp recordings from hippocampal CA1
interneurons were performed using patch pipettes (2–5 MΩ)
pulled from borosilicate glass (8250 1.65/1.0 mm) on a Narishige
PC-10 pipette puller filled with (in mM): KCl 55, KGluc
70, NaCl 8, MgATP 2, NaGTP 0.1, HEPES 10, BAPTAK4
2, QX314 chloride 10, biocytin 0.1% or KGluc 130, NaCl 8,
MgATP 2, NaGTP 0.1, HEPES 10, BAPTAK4 0.1, biocytin
0.1%. Elevated intracellular KCl, BAPTAK4, and the inclusion
of QX314 in the intracellular solution were used for the
measurement of spontaneous inhibitory postsynaptic currents
(IPSCs), which appear as inward or negative going currents
in voltage clamped current recordings (Vh = −70 mV).
Otherwise, a standard KGluc and lower BAPTAK4 intracellular
solutions where used to measure membrane potential responses.
Membrane potentials and/or currents were measured with
a Model 2400 patch clamp amplifier (A-M Systems, Port
Angeles, WA) and converted into a digital signal by a
PCI-6040E A/D board (National instruments, Austin, TX).
WCP Strathclyde Software was used to store and analyze
membrane potential and current responses on a PC computer
(courtesy of Dr. J Dempster, Strathclyde University, Glasgow,
Scotland). To detect and analyze spontaneous inhibitory
postsynaptic currents (sIPSCs), miniAnalysis (Synaptosoft, Fort
Lee, NJ) was used. Further analysis was performed with
Originpro 8.1 (OriginLab Corp., Northampton, MA, USA),
Excel (Microsoft, Redmond, WA) and SPSS 20.0 (IBM,
Armonk, NY).
Immunofluorescence: Morphological
Reconstruction of Interneurons Displaying
Nicotinic and Muscarinic Responses and
Amplification of Fluorescent Markers
Slices were fixed in 4% paraformaldehyde (Boston BioProducts)
and incubated with streptavidin Alexa Fluor 633 (Life
Technologies, Invitrogen) in phosphate buffered saline
(PBS) with Triton-X 100 as previously described (Bell et al.,
2011). Processed slices were then reconstructed using a Zeiss
LSM 710 confocal microscope (Carl Zeiss, Jena, Germany).
Alexa Fluor 633 was excited with the 633 nm line of a
HeNe 5 mW laser and cells were visualized using a 20×
dry lens (0.8 N.A., voxel dimensions 0.2 × 0.2 × 1.1 µm).
The imaged interneurons were traced using the Autoneuron
module within the Neurolucida program (MBP, Burlington,
VT). For amplification of YFP-labeled interneurons, 1:200
dilution of rabbit anti-GFP conjugated to Alexa Fluor 488
(Life Technologies, Invitrogen) in goat blocking buffer (10%
normal serum, 2% bovine serum albumin, 0.4% Triton-X 100
in 0.1 M phosphate buffer) was added to fixed and washed
slices for overnight incubation. Before and after primary
and secondary antibody incubations, slices were washed
in PBS. Slices were mounted in either Prolong Gold® (Life
Technologies, Invitrogen) or VECTASHIELD® hard mount
(Vector Laboratories).
Statistics and Data Analysis
Data were analyzed using WCP software and miniAnalysis
for the electrophysiological measurements. Statistics were
performed using SPSS 20.0 (IBM, Armonk, NY). Statistical
significances for groups of 3 or more were determined using a
one-way ANOVA with Bonferroni post hoc tests. The averaged
statistical significances for groups of 2 were determined with
two-tailed t-tests. For averaged time-dependent sIPSC frequency
data, a one-way ANOVA was done to test whether the
averaged sIPSC frequency changed over the course of each
experiment. Differences were determined to be statistically
significant for p values less than 0.05. All data was reported as
the mean, standard error of the mean (SEM). Asterisks were
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as follows unless otherwise noted, ∗∗∗p < 0.001, ∗∗p < 0.01,
∗p< 0.05.
Chemicals
All chemicals were purchased from VWR unless otherwise
indicated. VU 10010 (M4-selective positive allosteric
modulator), SR 95531 hydrobromide (Gabazine, GABAA
antagonist), Baclofen (GABAB antagonist), QX314 chloride
(intracellular sodium channel blocker), and AF-DX 116 (selective
M2- muscarinic receptor antagonist) were obtained from Tocris
Bioscience (Ellisville, Missouri) and 6, 7-Dinitroquinoxaline-2,
3-dione (DNQX, AMPA receptor antagonist), DL-2-Amino-5-
phosphono pentanoic acid (APV, NMDA receptor antagonist)
from Ascent Scientific (Bristol, U.K.). Biocytin (B-1592) was
purchased from Life Technologies (Invitrogen).
Results
ACh Released from MS/DBB Terminals
Selectively Produced α4β2∗ Nicotinic Responses
in VIP Interneuron-Selective Interneurons
There are two types interneurons that express vasoactive-
intestinal peptide (VIP) in hippocampal CA1: those that
exclusively innervate other interneurons (interneuron-selective
interneurons, VIP/IS) and those that innervate the perisomatic
region of pyramidal neurons (VIP basket cells, VIP/BC) (Acsády
et al., 1996b). While nicotinic responses appear to occur in
neocortical VIP interneurons (Arroyo et al., 2012), little is
known about how hippocampal VIP interneurons respond to
ACh released from MS/DBB cholinergic terminals. Therefore,
we investigated the actions of ACh release on VIP interneurons
using whole cell patch clamp recordings and optogenetics in
acute mouse hippocampal brain slices. To target whole cell
patch clamp recordings from VIP interneurons, we utilized CVY
animals (see methods) that expressed YFP in VIP interneurons.
To optogenetically release ACh from MS/DBB cholinergic
terminals in hippocampal brain slices, we expressed the
excitatory optogenetic protein oChIEF-tdTomato in MS/DBB
cholinergic neurons through Cre-dependent AAV mediated
transfection. Following whole cell patch clamp measurements,
interneurons were morphologically reconstructed to determine if
the interneuron fromwhich we recorded was either a perisomatic
projecting basket cell or an interneuron-selective interneuron
(Figure 1A, VIP/IS). Cells with incomplete morphology were
labeled ‘‘noID’’ (VIP/noID).
In a previous study, we demonstrated that all morphologically
identified VIP basket cells responded to ACh release with a
muscarinic receptor-dependent slow depolarization completely
inhibited by atropine (Bell et al., 2015). In the present study,
we attempted to preferentially record from VIP/IS cells by
targeting recordings to small VIP fluorescent neurons in the
middle of the stratum lacunosum-moleculare (SLM). These
SLM interneurons had smaller cell bodies (≤10 um) that
have been correlated with VIP/IS cells and not VIP basket
cells (Acsády et al., 1996a). In most VIP/IS cells (19 of 21)
and all small cell bodied SLM VIP/noID cells (15 of 15)
optogenetically released ACh resulted in depolarizations that
increased in amplitude in the presence of atropine (Figures 1C,
2A–E,I). The nicotinic responses were not significantly affected
by bath application of the α7 nicotinic receptor antagonist MLA
(25 nM, Figures 1A,B, gray, n = 12), but they were blocked
by bath application of the α4β2∗ nicotinic receptor antagonist
DHβE (1 µM, Figures 1A,B, orange, one-way ANOVA, p <
0.001, Bonferroni post hoc p < 0.001, n = 20) suggesting that
they were mediated by α4β2∗ nicotinic receptors (Bell et al.,
2011). Anatomical reconstruction of some nicotinic responding
interneurons displayed morphology similar to that described
for type 2 VIP/IS interneurons (Figure 1A; Acsády et al.,
1996a) whereas others could not be definitively correlated with
previously described classes of VIP/IS interneurons because
of limited axonal morphology. Electrophysiological properties
of nicotinic responding VIP interneurons were diverse. The
average resting membrane potential for nicotinic responding
VIP interneurons was −73.9 mV ± 0.8 mV (n = 30) and the
average input resistance was 395.3 MΩ, ± 20.8 MΩ (n = 30).
The nicotinic responsive interneurons showed no consistent
active membrane properties. Some interneurons displayed
irregular action potential firing patterns (Figures 1D–F)
whereas others had regular accommodating action potential
firing patterns (Figure 1G) (average accommodation ratio
(last interval/first interval) 2.75 ± 0.84, n = 30). Many
nicotinic receptor responding interneurons had decreasing
action potential amplitudes during depolarizing test pulses
(ratio last/first = 0.34, ± 0.07, n = 30) (Figures 1D,F).
Furthermore, different nicotinic responding VIP interneurons
could either display a voltage sag (Figure 1G) or it could
be absent during hyperpolarizations (Figures 1D,F) (average
sag ratio of 1.09 ± 0.01, n = 30). Therefore, nicotinic
responding VIP interneurons could not be classified based
on electrophysiological properties. In contrast to VIP/IS
interneurons, endogenous nicotinic excitatory responses were
not observed in VIP basket cells, parvalbumin interneurons,
or pyramidal neurons (Bell et al., 2015, data not shown).
Thus, nicotinic responses resulting from ACh release may
preferentially occur in interneuron-selective interneurons.
Nicotinic Responses in VIP/IS Interneurons are
Presynaptically Inhibited by M2 Autoreceptors
In order determine whether muscarinic receptors contributed
to depolarizing responses in VIP/IS interneurons, we bath
applied atropine to inhibit muscarinic receptors. Rather than
inhibiting the depolarization, atropine potentiated this response
(Bell et al., 2011). This potentiation was independent of the
number (10—Figure 2A vs. 120—Figures 2B,C) or frequency
of pulses (20 Hz—Figures 2A,B vs. 8 Hz—Figure 2C). In
some VIP/IS interneurons (5 of 20), previously subthreshold
nicotinic responses could become suprathreshold following the
application of atropine (Figures 2A–C). On average, the presence
of atropine resulted in a 283 ± 30% increase in the area
of the response (Figure 2D, t-test, p < 0.001, n = 20). To
test whether this potentiation was due to a presynaptic or
postsynaptic mechanism, we blocked postsynaptic G-protein
coupled signaling by substituting GTP with GDP-β-S in the
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FIGURE 1 | Acetylcholine (ACh) release activates α4β2∗-nicotinic
receptors on vasoactive-intestinal peptide (VIP) interneuron-selective
interneurons. (A) VIP interneuron-selective (IS) interneuron (morphology, A1)
responded to optogenetically released ACh with fast depolarizations (black
traces, 10 × 20 Hz) that were inhibited by 1 µM DHβE (orange traces) but not
25 nM MLA (gray trace). (B) All VIP interneurons not displaying basket cell
morphology were unaffected by bath application of 25 nM MLA (gray bar,
n = 12) but were blocked by 1 µM DHβE (orange bar, one-way ANOVA,
p < 0.001, Bonferroni post hoc p < 0.001, n = 20). (C) Histogram illustrating the
distribution of response types across VIP expressing interneurons: VIP/IS cells,
and VIP/noID. Most VIP/IS cells (19 of 21) and all non-visually identified VIP cells
(19 of 19) exhibited nicotinic-dependent depolarizations (purple). (D–F) Example
of VIP interneurons with nicotinic responses that displayed irregular action
potential firing patterns that decreased in amplitude in response to depolarizing
current injection. Negative current pulses produced hyperpolarizing membrane
responses with little or no voltage sag. (G) A VIP interneuron that produced
accommodating regular action potential firing patterns to depolarizing current
injection and a hyperpolarizing sag in response to negative current injection.
intracellular solution. When postsynaptic G-protein signaling
was blocked, atropine continued to potentiate the nicotinic
response (Figures 2E,I, one-way ANOVA, p< 0.001, Bonferroni
post hoc test p < 0.001, n = 7) suggesting that ACh release
from MS/DBB terminals onto nicotinic receptors is inhibited by
presynaptic muscarinic autoreceptors.
We next determined whether GDP-β-S effectively blocked
postsynaptic G-protein coupled signaling in our experimental
system. To do this we bath applied the GABAB agonist
baclofen (10 µM) and measured hyperpolarizing responses
in VIP/IS interneurons. In all cells where GTP was included
in the intracellular solution (Figures 2J,K, black), baclofen
caused a large sustained hyperpolarization (average amplitude
at 4.5 min application = −11.6 ± 0.8 mV, one-way ANOVA,
p < 0.001, Bonferroni post hoc p < 0.01 for time points
4–7 min, n = 4). In contrast, baclofen had no significant effect
on the membrane potential of VIP/IS interneurons in which
GDP-β-S was included in the intracellular solution (average
amplitude at 4.5 min application =−1.1± 0.9 mV, Figures 2J,K,
blue, one-way ANOVA, ns, n = 4). Therefore, inclusion of
GDP-β-S in the intracellular solution was effective in blocking
postsynaptic G-protein coupled signaling and the atropine
mediated potentiation of the nicotinic response was at least in
part mediated by a presynaptic mechanism.
To examine which muscarinic receptor subtype mediated
this presynaptic inhibition, we tested whether the M2-selective
antagonist AF-DX 116 or the M4 positive allosteric modulator
VU 10010 affected the nicotinic response. M4 receptors appeared
to have no role in mediating presynaptic inhibition as VU
10010 (5 µM) had no effect on nicotinic response amplitudes
(Figures 2G,I one-way ANOVA, ns, n = 5). In contrast, AF-
DX 116 (500 nM) (Figures 2F,I) significantly increased the
size of nicotinic responses suggesting that ACh release from
MS/DBB terminals onto VIP/IS interneurons was inhibited
by presynaptic M2 receptors (Figure 2I, one-way ANOVA,
p < 0.001, Bonferroni post hoc test p < 0.001, n = 6).
The magnitude of the potentiation by AF-DX116 was similar
to that produced by atropine (Figure 2I) suggesting M2
receptors were involved. Furthermore, prior application of AF-
DX116 occluded the effect of atropine on nicotinic response
amplitudes (Figures 2H,I, t-test, ns, n = 6). Therefore, M2
muscarinic receptors mediate most if not all of the inhibition of
ACh release.
Postsynaptic Targets of Interneurons Excited by
Nicotinic Receptor Activation
We next investigated the downstream effects of the interneurons
that were excited by nicotinic receptor activation. We recorded
changes produced by nicotinic receptor activation on the
frequency of sIPSCs in different CA1 interneuron subtypes
located in the dendritic layers of CA1 (Figures 3A–H), CA1
pyramidal cells (Figures 3I–L), and layer 2/3 neocortical
pyramidal neurons (Figures 3M–P). To increase the amplitudes
of sIPSCs and improve their detection, recordings were made
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FIGURE 2 | Presynaptic M2 autoreceptors inhibit the release of ACh
onto α4β2∗ nicotinic receptors in VIP/IS interneurons.
(A–C) Optogenetically released ACh produced depolarizing responses to
short/fast (A, 10 × 20 Hz), prolonged/fast (B, 120 × 20 Hz), and
prolonged/slow (C, 120 × 8 Hz) blue light flashes (black traces). The
depolarizations were potentiated by 10 µM atropine (green traces). (D) Atropine
(green) significantly potentiated the area of the nicotinic response (normalized to
control, black, 10 × 20 Hz) (t-test, p < 0.001, n = 0). (E). Inclusion of GDP-β-S
(black trace) in the intracellular recording solution did not inhibit atropine (green
trace) potentiation of the nicotinic responses. (F) M2 antagonist AF-DX 116
(500 nM, red trace) potentiated nicotinic responses when GDP-β-S was
included in the intracellular solution. (G) M4 positive allosteric modulator VU
10010 did not affect nicotinic responses (one-way ANOVA, ns, n = 5). (H) M2
antagonist AF-DX 116 (500 nM, red trace) occluded atropine (green trace)
potentiation of nicotinic responses. (I) Histogram showing that atropine
(GDP-β-S) (one-way ANOVA, p < 0.001, Bonferroni post hoc test p < 0.001,
n = 7) and AF-DX 116 (GDP-β-S) (Bonferroni post hoc test p < 0.001, n = 6)
significantly potentiated nicotinic responses. Atropine (green checkers) did not
significantly increase nicotinic responses previously potentiated by AF-DX 116
(GDP-β-S) (t-test, ns, n = 6). (J) Application of 10 µM baclofen hyperpolarized
VIP interneurons (black trace) but not when GDP-β-S (blue trace) was included
in the intracellular solution. (K) All VIP interneurons tested produced significant
hyperpolarizations when exposed to baclofen (black dots, one-way ANOVA,
p < 0.001, Bonferroni post hoc p < 0.01 for time points 4–7 min, n = 4).
Recordings that included GDP-β-S in the patch pipette did not respond to
baclofen application (blue dots, one-way ANOVA, ns, n = 4).
with elevated intracellular chloride, QX314 to block action
potentials that escaped voltage clamp, and elevated BAPTA to
maintain low intracellular calcium levels. Under these recording
conditions, voltage clamped sIPSCs resulted in inward currents.
In all experiments, muscarinic receptors were blocked by
atropine, ionotropic glutamate receptors were blocked by DNQX
(30 µM) and APV (50 µM), and GABAB receptors were blocked
by CGP54626 (1 µM). ACh was released by 10 × 1 ms flashes
of blue light at 20 Hz at 1 min intervals. Peristimulus-time
histograms for sIPSCs were constructed to detect any changes in
the average time-dependent sIPSC frequency.
Following the activation of nicotinic receptors by the
optogenetic release of ACh, approximately half of dendritically
located hippocampal CA1 interneurons (23 of 49 non VIP
expressing, morphologically unidentified) displayed an increase
in average sIPSC frequency (Figures 3B–D). One example
illustrated that ACh release caused the time-dependent sIPSC
frequency to increase from 0.035–0.231 Hz (Figure 3C). When
normalized and averaged across all interneuron recordings, the
average time-dependent sIPSC frequency increased by 574%
(± 283%) during and immediately after 500 (ms after last flash)
light flashes (Figure 3D, one-way ANOVA, p < 0.01, n = 23).
This increase in frequency was subsequently blocked by bath
application of DHβE (1 µM) suggesting that α4β2∗ nicotinic
receptors mediated the excitation of presynaptic interneurons
(Figure 3D, one-way ANOVA, ns relative to control, n = 8). In
order to determine whether VIP interneurons were the exclusive
presynaptic interneurons activated by ACh release, Arch-GFP
was expressed in VIP interneurons (Bell et al., 2015). When
Arch was expressed in VIP-Cre interneurons, we found that a
yellow light pulse did not affect the increased frequency of sIPSCs
produced by ACh release (Figures 3F–H, one-way ANOVA, ns,
n = 21). This suggested that other non-VIP/IS interneurons also
respond to ACh release through the activation of α4β2∗ nicotinic
receptors.
Hippocampal CA1 interneurons are inhibited by
interneuron-selective interneurons as well as interneurons
that innervate both interneurons and pyramidal cells. Therefore,
we examined whether the non-VIP interneurons activated by
nicotinic receptors inhibited pyramidal neurons in addition to
interneurons. In all morphologically identified CA1 pyramidal
neurons examined (n = 42), no change in time-dependent sIPSC
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FIGURE 3 | ACh release drives nicotinic receptor-mediated
feedforward inhibition onto CA1 interneurons but not CA1 pyramidal
neurons. (A,E,I,M) Schematic drawings of four recording paradigms.
sIPSCs were recorded in response to ACh release in non-VIP CA1
interneurons located at the border of SR and SLM (A–H), in CA1 pyramidal
neurons (I–L), or in layer 2/3 neocortical pyramidal neurons (M–P). All
recordings were performed in the presence of 10 µM atropine, 30 µM
DNQX, and 50 µM APV. (B) Voltage clamp recordings (Vh = −70 mV)
demonstrating that optogenetic release of ACh (blue bars, 10 × 20 Hz)
increased the number of sIPSCs observed in CA1 non-VIP interneurons.
(C) A peristimulus time histogram (PSTH) illustrating the increase in
time-dependent sIPSC frequency in nonVIP interneurons following ACh
release. (D) An increase in the averaged time-dependent sIPSC frequency
across all non-VIP interneurons (black line, gray shading = S.E.M, one-way
ANOVA compared to baseline, p < 0.01, n = 23) was completely blocked
by 1 µM DHβE (orange line, orange shading = SEM, one-way ANOVA, ns
compared to baseline, n = 8). (F) Voltage clamp recordings showing that
suppression of VIP interneurons by yellow light activation of Arch (yellow
bar) did not inhibit the increase in sIPSC frequency following ACh release
(blue bars). (G) PSTH showing time-dependent sIPSC frequency following
ACh release persisted in the presence of yellow light (yellow bar). (H) The
increased averaged time-dependent sIPSC frequency measured across all
non-VIP interneurons (black line, gray shading = S.E.M, one-way ANOVA,
p < 0.001, n = 21) was not suppressed by activation of Arch in VIP
interneurons. (J) Voltage clamp recordings from a CA1 pyramidal neuron
showed no change in sIPSC frequency following ACh release (blue bars).
(K) PSTH demonstrated that the time-dependent sIPSC frequency was
unchanged following ACh release in an individual CA1 pyramidal neuron.
(L) Averaged time-dependent sIPSC frequency across all CA1 pyramidal
cell recordings demonstrated no change sIPSC frequency following ACh
release (black line, gray shading = S.E.M, one-way ANOVA, ns, n = 42).
(N) Voltage clamp recordings from a neocortical pyramidal neuron
demonstrated that ACh release produced an increase in sIPSC frequency.
(O) PSTH demonstrated that the time-dependent frequency of sIPSCs in
the neocortical pyramidal neuron increased following ACh release. (P) The
averaged time-dependent sIPSC frequency in all measured neocortical
pyramidal neurons increased following ACh release (black line, gray
shading = S.E.M., one-way ANOVA, p < 0.001, n = 5) and was blocked by
1 µM DHβE (orange line, orange shading = S.E.M., one-way
ANOVA, ns, n = 5).
frequency was observed during or following the release of ACh
(Figures 3J–L). Furthermore, normalization and averaging the
time-dependent sIPSC frequency across all pyramidal neurons
showed no significant increase in sIPSC frequency following
ACh release compared to baseline sIPSC frequency (Figure 3L,
one-way ANOVA, ns, n = 42). These observations were
somewhat unexpected as previous studies had suggested that
ACh release may activate nicotinic receptors on interneurons
that innervate CA1 pyramidal neurons (Nagode et al., 2011).
Furthermore, neocortical interneurons that innervate layer
2/3 pyramidal neurons have been shown to be excited by
ACh release onto nicotinic receptors (Arroyo et al., 2012).
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Therefore, to test whether in our system we can activate nicotinic
receptors on interneurons that innervate pyramidal neurons,
we expressed oChIEF-tdTomato in cholinergic neurons of the
nucleus basalis. This permitted us to record from layer 2/3
pyramidal neurons of the neocortex and measure changes in
sIPSC frequency following ACh release (Figures 3N–P). Similar
to previous reports (Arroyo et al., 2012), ACh release increased
the time-dependent frequency of sIPSC in neocortical pyramidal
neurons (Figures 3N–P, one-way ANOVA, p < 0.001, n = 5)
and the increased frequency was blocked by DHβE (1 µM,
one-way ANOVA, ns relative to control, n = 5). Therefore,
our data suggested that ACh release onto nicotinic receptors
in hippocampal CA1 preferentially activates interneurons that
innervate other interneurons rather than interneurons that
inhibit pyramidal neurons.
Discussion
Our data suggest that nicotinic transmission preferentially
engages specific networks in hippocampal CA1. Without
affecting pyramidal neurons, nicotinic cholinergic transmission
activated very specific groups of interneurons in hippocampal
CA1 that selectively inhibit other interneurons (interneuron-
selective interneurons). Release of ACh appeared to activate
nicotinic receptors on both VIP and non-VIP interneuron-
selective interneurons. Importantly, nicotinic responses
were potently controlled by M2 muscarinic receptor-driven
presynaptic inhibition.
Our data confirmed previous reports from our laboratory
that suggested that hippocampal CA1 interneurons can be
excited by ACh released onto postsynaptic α4β2∗ nicotinic
receptors (Bell et al., 2011). Our current studies extend
these findings by demonstrating that α4β2∗-mediated nicotinic
responses preferentially occurred in morphologically identified
VIP/IS interneurons. We did not observe nicotinic responses in
VIP/BCs, PV interneurons or pyramidal neurons. Furthermore,
disynaptic IPSCs produced by nicotinic receptor activation
were only detected in interneurons and not pyramidal cells.
Importantly, these disynaptic IPSCs were not inhibited by
optogenetic silencing of VIP interneurons suggesting that
other non-VIP-expressing interneuron-selective interneurons
were also excited by the release of ACh onto α4β2∗ nicotinic
receptors (Acsády et al., 1996b; Gulyás et al., 1996). This may be
expected as VIP/IS interneurons only make up a minority (37%)
of interneuron-selective interneurons (Acsády et al., 1996a).
Importantly, a significant portion of the interneurons innervated
by interneuron-selective interneurons target the dendrites of
CA1 pyramidal neurons (Acsády et al., 1996a; Gulyás et al.,
1996). Therefore, nicotinic disinhibition in hippocampal CA1
may facilitate dendritic integration of synaptic inputs in CA1
pyramidal neurons.
It should be noted that the triple crosses in the experiments
described above should result in the expression of Arch-GFP
in both VIP and cholinergic neurons (CVA animals). This
could make interpretation of the results from these experiments
difficult as an inhibition of the nicotinic receptor-driven response
might result from the inhibition of VIP neurons or the inhibition
of cholinergic terminals. However, activation of Arch in our
preparation had no effect on the nicotinic driven inhibitory
postsynaptic currents measured in interneurons. Thus, Arch
must not be expressed at sufficient concentrations in cholinergic
terminals to influence optogenetically-driven release of ACh.
Our nicotinic data were inconsistent with previous findings
that suggested that CA1 pyramidal neurons (∼20%) (Gu and
Yakel, 2011) and interneurons that innervate pyramidal neurons
(Nagode et al., 2011) may be excited by ACh released onto
nicotinic receptors. Although we have never observed a nicotinic
response in recordings from 132 pyramidal neurons or 104
non IS interneuron subtypes, it is possible that we did not
sample enough neurons or had a bias toward recording from
particular interneuron subtypes. Furthermore, different injection
methods and excitatory optogenetic proteins used between the
different studies may have limited our ability to record nicotinic
responses in pyramidal neurons or interneurons that innervated
pyramidal cells. Alternatively, the studies that reported nicotinic
responses in other cell types did not confirm the recorded
neurons identity with post hoc anatomical reconstructions
or electrophysiological characterization. Therefore, it remains
possible that the nicotinic responses (Gu and Yakel, 2011)
and nicotinic receptor-driven disynaptic IPSCs (Nagode et al.,
2011) measured in putative pyramidal neurons were actually
recordings made from interneurons and not pyramidal cells.
Another possibility for the lack of nicotinic receptor-driven
disynaptic IPSCs in pyramidal neurons observed in our study
may be that nicotinic responses in interneurons that target
pyramidal neurons are mostly subthreshold. Regardless of
these inconsistencies, our data suggest that a primary effect
of α4β2∗ nicotinic receptor-mediated transmission is to excite
interneuron-selective interneurons and aid in disinhibition of the
hippocampal CA1 network.
Nicotinic receptor-mediated transmission in hippocampal
CA1 has been shown to be potently inhibited by the release
of ACh onto muscarinic receptors (Bell et al., 2011). Here
we demonstrated that the muscarinic receptor inhibition of
nicotinic transmission persisted when postsynaptic G-protein
functioning was blocked—suggesting a presynaptic mechanism.
This presynaptic inhibition of ACh release appears to be
mediated by M2 muscarinic receptors, similar to findings in the
thalamus (Sun et al., 2013). Importantly, muscarinic receptor
presynaptic inhibition was potent and often prevented nicotinic
responses from eliciting action potentials in interneuron-
selective interneurons. Thus, therapeutic pharmacological
blockade of M2 muscarinic receptors would be expected to
facilitate nicotinic receptor-mediated influence on disinhibitory
circuitry in hippocampal CA1.
Similar to our findings in the hippocampus, nicotinic
receptor-mediated disinhibition has been observed in the
auditory cortex (Letzkus et al., 2011). Some of the neocortical
interneurons excited by ACh release expressed Chat, which
has been shown to be expressed exclusively in VIP-expressing
interneurons (Porter et al., 1998; Gonchar et al., 2008). However,
unlike our studies, nicotinic transmission was observed in
interneurons that innervated both pyramidal neurons and other
interneurons (Arroyo et al., 2012). Therefore, the effect of
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nicotinic receptor-mediated transmission in the neocortex will
likely be more complex than a primarily disinhibitory role that
we hypothesize for the hippocampus.
Summary
Optogenetic techniques have recently permitted more extensive
studies on the effect of ACh release in various regions of the
CNS. In particular, nicotinic responses to ACh release have been
studied in several brain regions including the interpeduncular
nucleus (Ren et al., 2011), hippocampus (Bell et al., 2011),
striatum (English et al., 2011), neocortex (Letzkus et al., 2011;
Arroyo et al., 2012), spinal cord (Lamotte d’Incamps et al.,
2012) and thalamus (Sun et al., 2013). A common feature of
these responses is that they activate GABAergic neurons. In
some areas, nicotinic receptors activate GABAergic projection
neurons (Ren et al., 2011; Sun et al., 2013). In other regions,
they activate select types of inhibitory interneurons (Bell
et al., 2011; English et al., 2011; Arroyo et al., 2012). The
impact that physiologically activated nicotinic receptors have
in each brain region will depend on the specific types of
GABAergic neurons activated by ACh release. In the case of
hippocampal CA1, interneuron-selective interneurons appear to
be preferentially activated by nicotinic receptors suggesting a
feedforward disinhibitory role for nicotinic receptor-mediated
transmission.
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